UCR Startup Receives $2.25 Million to Test New Cancer Drug
Riverside company's treatment targets aggressive tumors including pancreatic cancer.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
A prompt to encourage your practice of creativity this week from Riversider and local author Larry Burns.
Let us email you Riverside's news and events every morning. For free!